+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GLHRL GLHRL

Global Longlife Hospital and Research Share Price

₹13.72 +0.65 (4.97%)
46.82% Fall from 52W High

03 Nov, 2026 4:01 PM (IST)

Global Longlife Hospital and Research live price: ₹13.72. It opened at ₹14 vs previous close ₹13; intraday high/low: ₹14/₹12. The 50 & 200 DMA stand at ₹12.70/₹14.80.

Global Longlife Hospital and Research Performance

  • Today's Low
  • ₹12
  • Today's High
  • ₹14
  • 52 Week Low
  • ₹9
  • 52 Week High
  • ₹26
  • Open Price₹14
  • Previous Close₹13
  • Volume140,000
  • 50 DMA₹12.70
  • 100 DMA₹12.90
  • 200 DMA₹14.80

Global Longlife Hospital and Research Chart

Investment Returns

  • Over 1 Month + 12.92%
  • Over 3 Month + 17.26%
  • Over 6 Month + 8.12%
  • Over 1 Year -42.16%

Smart Investing Starts Here Start SIP with Global Longlife Hospital and Research for Steady Growth!

Invest Now

Global Longlife Hospital and Research Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -8.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 14
  • P/B Ratio
  • 0.6
  • Average True Range
  • 1
  • EPS
  • -1.6
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 58.84
  • MFI
  • 90.71

Latest Stock News Updates

Global Longlife Hospital and Research Ltd - 543520 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Voting Results in respect of First Extra Ordinary General Meeting held on October 30, 2026

Global Longlife Hospital and Research Ltd - 543520 - Shareholder Meeting / Postal Ballot-Outcome of EGM

Proceedings of the First Extra Ordinary General Meeting of FY 2026-2027.

Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Half Year Ended On September 30, 2026.

Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for the Half year ended on September 30, 2026.

Global Longlife Hospital and Research Financials

Global Longlife Hospital and Research Technicals

EMA & SMA

Current Price
₹13.72
+ 0.65 (4.97%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹12.80
  • 50 Day
  • ₹12.70
  • 100 Day
  • ₹12.90
  • 200 Day
  • ₹14.80

Resistance and Support

13.27 Pivot Speed
  • R3 15.40
  • R2 14.60
  • R1 14.10
  • S1 12.90
  • S2 12.00
  • S3 11.60

Global Longlife Hospital and Research Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-04 Half Yearly Results
2026-05-07 Audited Results
2025-11-12 Half Yearly Results
2025-04-28 Audited Results
2024-10-28 Half Yearly Results

Global Longlife Hospital and Research Shareholding Pattern

99.98%
0.02%
0%

About Global Longlife Hospital and Research

Global Longlife Hospital & Research is an Ahmedabad, Gujarat-based multi-speciality tertiary care hospital certified by the NABH (National Accreditation Board for Hospitals and Healthcare Providers). Founded in 2012, the healthcare provider offers a wide array of medical, surgical, and diagnostic services with a strong focus on oncology, cardiology, and other allied specialities. View More
  • NSE Symbol
  • GLHRL
  • BSE Symbol
  • 543520
  • ISIN
  • INE0J2K01014

Similar Stocks to Global Longlife Hospital and Research

Global Longlife Hospital and Research FAQs

Global Longlife Hospital and Research share price is ₹13 As on 04 November, 2026 | 01:41

The Market Cap of Global Longlife Hospital and Research is ₹14.4 Cr As on 04 November, 2026 | 01:41

The P/E ratio of Global Longlife Hospital and Research is -8.4 As on 04 November, 2026 | 01:41

The PB ratio of Global Longlife Hospital and Research is 0.6 As on 04 November, 2026 | 01:41

The 52 week High & Low of Global Longlife Hospital and Research is ₹25.8/₹9 respectively As on 04 November, 2026 | 01:41

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23